Search

Lisa M Turin

from Redwood City, CA
Age ~66
Get Report
Also known as:
Lisa Marie Turin, Lisa Tyrin
Phone and address:
2507 Hastings Shore Ln, Redwood City, CA 94065
(650) 596-7157
Related to:
Nancy L Mead, 65Jennifer J Turin, 70C Anna Robinson, 89Winoka H Turin, 62Paul S Turin, 63Anna Robinson Cleary, 89P Turin
Connected to:
Daniel Turini, 52Adam W Turinsky, 36Benjamin D Turk, 44Devin J Turk, 35Diane Turk, 63Ehab E Turk, 51Faith R Turk, 67Krista D Turk, 30Miriam A Turk, 67Valerie J Turk, 83

Lisa Turin Phones & Addresses

  • 2507 Hastings Shore Ln, Redwood City, CA 94065 (650) 596-7157
  • 2708 Hastings Shore Ln, Redwood City, CA 94065
  • Berkeley, CA
  • Milpitas, CA
  • PO Box 7086, Redwood City, CA 94063 (650) 596-7157

Work

Position: Administrative Support Occupations, Including Clerical Occupations

Education

Degree: High school graduate or higher

Publications

Us Patents

Sequence Directed Dna Binding Molecules Compositions And Methods

View page
US Patent:
6384208, May 7, 2002
Filed:
Jul 15, 1999
Appl. No.:
09/354947
Inventors:
Cynthia A. Edwards - Menlo Park CA
Charles R. Cantor - Boston MA
Beth M. Andrews - Maynard MA
Lisa M. Turin - Redwood City CA
Kirk E. Fry - Palo Alto CA
Assignee:
Genelabs Technologies, Inc. - Redwood City CA
International Classification:
C07H 2104
US Classification:
536 241, 536 231
Abstract:
The present invention defines a DNA: protein-binding assay useful for screening libraries of synthetic or biological compounds for their ability to bind DNA test sequences. The assay is versatile in that any number of test sequences can be tested by placing the test sequence adjacent to a defined protein binding screening sequence. Binding of molecules to these test sequence changes the binding characteristics of the protein molecule to its cognate binding sequence. When such a molecule binds the test sequence the equilibrium of the DNA:protein complexes is disturbed, generating changes in the concentration of free DNA probe. Numerous exemplary target test sequences (SEQ ID NO:1 to SEQ ID NO:600) are set forth. The assay of the present invention is also useful to characterize the preferred binding sequences of any selected DNA-binding molecule.

Sequence-Directed Dna-Binding Molecules Compositions And Methods

View page
US Patent:
6869765, Mar 22, 2005
Filed:
Nov 13, 2001
Appl. No.:
09/993346
Inventors:
Cynthia A. Edwards - Menlo Park CA, US
Charles R. Cantor - Del Mar CA, US
Beth M. Andrews - Maynard MA, US
Lisa M. Turin - Redwood City CA, US
Kirk E. Fry - Palo Alto CA, US
Assignee:
Genelabs Technologies, Inc. - Redwood City CA
International Classification:
C12Q001/68
US Classification:
435 6, 435 4, 435 71
Abstract:
The present invention defines a DNA: protein-binding assay useful for screening libraries of synthetic or biological compounds for their ability to bind DNA test sequences. The assay is versatile in that any number of test sequences can be tested by placing the test sequence adjacent to a defined protein binding screening sequence. Binding of molecules to these test sequence changes the binding characteristics of the protein molecule to its cognate binding sequence. When such a molecule binds the test sequence the equilibrium of the DNA:protein complexes is disturbed, generating changes in the concentration of free DNA probe. Numerous exemplary target test sequences (SEQ ID NO:1 to SEQ ID NO:600) are set forth. The assay of the present invention is also useful to characterize the preferred binding sequences of any selected DNA-binding molecule.

Screening Assay For The Detection Of Dna-Binding Molecules

View page
US Patent:
57260141, Mar 10, 1998
Filed:
Sep 17, 1993
Appl. No.:
8/123936
Inventors:
Cynthia A. Edwards - Menlo Park CA
Charles R. Cantor - Boston MA
Beth M. Andrews - Watertown MA
Lisa M. Turin - Berkeley CA
Assignee:
Genelabs Technologies, Inc. - Redwood City CA
International Classification:
C12Q 168
C12P 1934
G01N 33566
US Classification:
435 6
Abstract:
The present invention defines a DNA:protein-binding assay useful for screening libraries of synthetic or biological compounds for their ability to bind DNA test sequences. The assay is versatile in that any number of test sequences can be tested by placing the test sequence adjacent to a defined protein binding screening sequence. Binding of molecules to these test sequence changes the binding characteristics of the protein molecule to its cognate binding sequence. When such a molecule binds the test sequence the equilibrium of the DNA:protein complexes is disturbed, generating changes in the concentration of free DNA probe. Numerous exemplary target test sequences (SEQ ID NO:1 to SEQ ID NO:600) are set forth. The assay of the present invention is also useful to characterize the preferred binding sequences of any selected DNA-binding molecule.

Method Of Determining Dna Sequence Preference Of A Dna-Binding Molecule

View page
US Patent:
58692410, Feb 9, 1999
Filed:
Jun 7, 1995
Appl. No.:
8/475228
Inventors:
Cynthia A. Edwards - Menlo Park CA
Charles R. Cantor - Boston MA
Beth M. Andrews - Maynard MA
Lisa M. Turin - Redwood City CA
Kirk E. Fry - Palo Alto CA
Assignee:
Genelabs Technologies, Inc. - Redwood City CA
International Classification:
C12Q 168
C12P 1934
US Classification:
435 6
Abstract:
The present invention defines a DNA:protein-binding assay useful for screening libraries of synthetic or biological compounds for their ability to bind DNA test sequences. The assay is versatile in that any number of test sequences can be tested by placing the test sequence adjacent to a defined protein binding screening sequence. Binding of molecules to these test sequence changes the binding characteristics of the protein molecule to its cognate binding sequence. When such a molecule binds the test sequence the equilibrium of the DNA:protein complexes is disturbed, generating changes in the concentration of free DNA probe. Numerous exemplary target test sequences (SEQ ID NO:1 to SEQ ID NO:600) are set forth. The assay of the present invention is also useful to characterize the preferred binding sequences of any selected DNA-binding molecule.

Sequence-Directed Dna-Binding Molecules Compositions And Methods

View page
US Patent:
55784445, Nov 26, 1996
Filed:
Dec 20, 1993
Appl. No.:
8/171389
Inventors:
Cynthia A. Edwards - Menlo Park CA
Charles R. Cantor - Boston MA
Beth M. Andrews - Maynard MA
Lisa M. Turin - Redwood City CA
Kirk E. Fry - Palo Alto CA
Assignee:
Genelabs Technologies, Inc. - Redwood City CA
International Classification:
C12Q 168
C12N 1500
G01N 33574
C07H 2102
US Classification:
435 6
Abstract:
The present invention defines a DNA:protein-binding assay useful for screening libraries of synthetic or biological compounds for their ability to bind DNA test sequences. The assay is versatile in that any number of test sequences can be tested by placing the test sequence adjacent to a defined protein binding screening sequence. Binding of molecules to these test sequence changes the binding characteristics of the protein molecule to its cognate binding sequence. When such a molecule binds the test sequence the equilibrium of the DNA:protein complexes is disturbed, generating changes in the concentration of free DNA probe. Numerous exemplary target test sequences (SEQ ID NO:1 to SEQ ID NO:600) are set forth. The assay of the present invention is also useful to characterize the preferred binding sequences of any selected DNA-binding molecule.

Sequence-Directed Dna Binding Molecules Compositions And Methods

View page
US Patent:
60108495, Jan 4, 2000
Filed:
Jun 7, 1995
Appl. No.:
8/482080
Inventors:
Cynthia A. Edwards - Menlo Park CA
Charles R. Cantor - Boston MA
Beth M. Andrews - Maynard MA
Lisa M. Turin - Redwood City CA
Kirk E. Fry - Palo Alto CA
Assignee:
Genelabs Technologies, Inc. - Redwood CA
International Classification:
C12Q 168
G01N 3353
US Classification:
435 6
Abstract:
The present invention defines a DNA:protein-binding assay useful for screening libraries of synthetic or biological compounds for their ability to bind DNA test sequences. The assay is versatile in that any number of test sequences can be tested by placing the test sequence adjacent to a defined protein binding screening sequence. Binding of molecules to these test sequence changes the binding characteristics of the protein molecule to its cognate binding sequence. When such a molecule binds the test sequence the equilibrium of the DNA:protein complexes is disturbed, generating changes in the concentration of free DNA probe. Numerous exemplary target test sequences (SEQ ID NO:1 to SEQ ID NO:600) are set forth. The assay of the present invention is also useful to characterize the preferred binding sequences of any selected DNA-binding molecule.
Control profile
Lisa M Turin from Redwood City, CA, age ~66 Get Report